In patients with ESCC, NSUN2 promotes ESCC progression and chemoresistance by promoting TIGAR (TP53 induced glycolysis regulatory phosphatase) (53) and GRB2 (growth factor receptor bound protein 2) (52). Here, NSUN2 is linked to esophageal squamous cell carcinoma.